Headquartered in Quimper, France, Polaris specializes in highly concentrated omega-3 and omega-6 oils. Its products are primarily used in nutraceuticals, as well as infant nutrition, cosmetics and animal feed. The company has built a strong position in its market, by leveraging its technological capabilities, proprietary labels and advanced formulation expertise.

Kevin Abrial, Partner at LGT Private Debt, said: “We are pleased to support Motion Equity Partners and Polaris as the company enters its next phase of growth. We believe the company is well positioned to benefit from positive long-term trends in health, wellness and science-backed nutrition. This transaction builds on our long-standing relationship with Motion Equity Partners and reflects our continued focus on high-quality businesses in the resilient, innovation-led healthcare and nutrition markets.”

Private debt is one of LGT Capital Partners' areas of expertise in the field of private markets. The team has been active in European direct lending since 2005, with offices in Paris, London and Frankfurt am Main. It has completed more than 130 investments since 2005. As a specialist in the European private debt market, it arranged the first unitranche transaction in Europe in 2007.